Diane W Chen1, Tao Wang2, Jonathan Shey-Sen Ni3, Vlad C Sandulache1, Evan M Graboyes3, Mitchell Worley3, Joshua D Hornig3, Judith M Skoner3, Terry A Day3, Andrew T Huang4. 1. Bobby R. Alford Department of Otolaryngology - Head and Neck Surgery, Baylor College of Medicine, Houston, TX, United States. 2. Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, United States. 3. Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, Charleston, SC, United States. 4. Bobby R. Alford Department of Otolaryngology - Head and Neck Surgery, Baylor College of Medicine, Houston, TX, United States. Electronic address: Andrew.Huang@bcm.edu.
Abstract
OBJECTIVE: Primary surgery followed by adjuvant therapy is the current standard of care in the multidisciplinary management of squamous cell carcinoma (SCC) of the oral tongue. Additionally, salvage glossectomy is used to treat recurrent base of tongue SCC. Microvascular free tissue transfer reconstruction (MVFTT) is utilized to maximize functional outcomes such as swallowing. We sought to identify prognostic factors related to achievement of a total oral diet in patients that underwent glossectomy with MVFTT. METHODS: Retrospective review at a tertiary care center from 2010 to 2015. RESULTS: 200 patients (69% male, mean age 60 years) met inclusion criteria. Extent of glossectomy was categorized as partial or hemiglossectomy (39%), tongue base resection with or without hemi-oral glossectomy (23%), composite resection with mandibulectomy (18%), and subtotal or total glossectomy (21%). Flap success rate was 96%. Median follow-up time was 14 months. A total oral diet was achieved by 49% of patients with median time to achievement of 31 days (IQR 9-209). Multivariate analysis identified body mass index < 25 kg/m2, prior radiation therapy, adjuvant chemoradiation, and resection requiring subtotal or total glossectomy or concurrent mandibulectomy as independent risk factors for worse total oral diet achievement. CONCLUSION: Swallowing dysfunction represents a significant morbidity following glossectomy in the treatment of SCC. High BMI, smaller resection fields, and absence of prior radiation therapy or adjuvant chemoradiotherapy correlated with improved likelihood of obtaining a total oral diet. Patients should be appropriately counseled of this risk with emphasis placed on aggressive swallow rehabilitation in the post- treatment setting.
OBJECTIVE: Primary surgery followed by adjuvant therapy is the current standard of care in the multidisciplinary management of squamous cell carcinoma (SCC) of the oral tongue. Additionally, salvage glossectomy is used to treat recurrent base of tongue SCC. Microvascular free tissue transfer reconstruction (MVFTT) is utilized to maximize functional outcomes such as swallowing. We sought to identify prognostic factors related to achievement of a total oral diet in patients that underwent glossectomy with MVFTT. METHODS: Retrospective review at a tertiary care center from 2010 to 2015. RESULTS: 200 patients (69% male, mean age 60 years) met inclusion criteria. Extent of glossectomy was categorized as partial or hemiglossectomy (39%), tongue base resection with or without hemi-oral glossectomy (23%), composite resection with mandibulectomy (18%), and subtotal or total glossectomy (21%). Flap success rate was 96%. Median follow-up time was 14 months. A total oral diet was achieved by 49% of patients with median time to achievement of 31 days (IQR 9-209). Multivariate analysis identified body mass index < 25 kg/m2, prior radiation therapy, adjuvant chemoradiation, and resection requiring subtotal or total glossectomy or concurrent mandibulectomy as independent risk factors for worse total oral diet achievement. CONCLUSION:Swallowing dysfunction represents a significant morbidity following glossectomy in the treatment of SCC. High BMI, smaller resection fields, and absence of prior radiation therapy or adjuvant chemoradiotherapy correlated with improved likelihood of obtaining a total oral diet. Patients should be appropriately counseled of this risk with emphasis placed on aggressive swallow rehabilitation in the post- treatment setting.
Authors: Urjeet A Patel; Gregory K Hartig; Matthew M Hanasono; Derrick T Lin; Jeremy D Richmon Journal: Otolaryngol Head Neck Surg Date: 2017-04-18 Impact factor: 3.497
Authors: Derrick T Lin; Bharat B Yarlagadda; Rosh K V Sethi; Allen L Feng; Yelizaveta Shnayder; Levi G Ledgerwood; Jason A Diaz; Parul Sinha; Matthew M Hanasono; Peirong Yu; Roman J Skoracki; Timothy S Lian; Urjeet A Patel; Jason Leibowitz; Nicholas Purdy; Heather Starmer; Jeremy D Richmon Journal: JAMA Otolaryngol Head Neck Surg Date: 2015-09 Impact factor: 6.223
Authors: Kevin Motz; Hsien-Yen Chang; Harry Quon; Jeremy Richmon; David W Eisele; Christine G Gourin Journal: JAMA Otolaryngol Head Neck Surg Date: 2017-06-01 Impact factor: 6.223
Authors: Vinidh Paleri; Mike Drinnan; Michiel W M van den Brekel; Michael L Hinni; Patrick J Bradley; Gregory T Wolf; Remco de Bree; Johannes J Fagan; Marc Hamoir; Primož Strojan; Juan P Rodrigo; Kerry D Olsen; Phillip K Pellitteri; Ashok R Shaha; Eric M Genden; Carl E Silver; Carlos Suárez; Robert P Takes; Alessandra Rinaldo; Alfio Ferlito Journal: Laryngoscope Date: 2014-03-11 Impact factor: 3.325
Authors: Peter T Dziegielewski; Michael L Ho; Jana Rieger; Prabhjyot Singh; Morgan Langille; Jeffrey R Harris; Hadi Seikaly Journal: Laryngoscope Date: 2012-09-05 Impact factor: 3.325
Authors: Sagar Kansara; Tao Wang; Sina Koochakzadeh; Nelson E Liou; Evan M Graboyes; Judith M Skoner; Joshua D Hornig; Vlad C Sandulache; Terry A Day; Andrew T Huang Journal: Oral Oncol Date: 2019-09-12 Impact factor: 5.337